Column Capital Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$8.27K Hold
17
﹤0.01% 548
2023
Q2
$7.6K Hold
17
﹤0.01% 569
2023
Q1
$8.25K Hold
17
﹤0.01% 585
2022
Q4
$8.71K Hold
17
﹤0.01% 549
2022
Q3
$8K Sell
17
-25
-60% -$12.2K ﹤0.01% 496
2022
Q2
$20K Sell
42
-15
-26% -$6.67K ﹤0.01% 389
2022
Q1
$25K Sell
57
-29
-34% -$12.1K ﹤0.01% 378
2021
Q4
$40K Buy
86
+4
+5% +$1.77K 0.01% 325
2021
Q3
$32K Buy
82
+25
+44% +$10.6K 0.01% 329
2021
Q2
$25K Hold
57
0.01% 360
2021
Q1
$24K Buy
57
+40
+235% +$16K 0.01% 358
2020
Q4
$7K Hold
17
﹤0.01% 499
2020
Q3
$7K Hold
17
﹤0.01% 491
2020
Q2
$6K Sell
17
-12
-41% -$4.49K ﹤0.01% 549
2020
Q1
$9K Sell
29
-75
-72% -$25.3K ﹤0.01% 406
2019
Q4
$38K Buy
+104
New +$33K 0.02% 277

Other funds holding HUM

Column Capital Advisors's HUM Position: Q3 2023 in Review

Column Capital Advisors held its Humana (HUM) position steady in Q3 2023 at 17 shares worth $8.27K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Column Capital Advisors first reported a position in HUM in Q4 2019 and has held it in 16 quarters since. The position peaked at $40K in Q4 2021. 1,087 funds tracked by Wall St. Rank hold HUM as of Q3 2023.

  • Column Capital Advisors held 17 shares of Humana worth $8.27K as of Q3 2023.
  • Column Capital Advisors left its Humana share count unchanged in Q3 2023.
  • Humana made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #548 holding.
  • Column Capital Advisors first reported a position in Humana in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Humana position peaked at $40K in Q4 2021.
  • 1,087 funds tracked by Wall St. Rank held Humana as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.